/
© 2026 RiffOn. All rights reserved.

Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

  1. The BioHub - by Avetix
  2. Episode 221 - Hans Schambye - CEO BOOST Pharma
Episode 221 - Hans Schambye - CEO BOOST Pharma

Episode 221 - Hans Schambye - CEO BOOST Pharma

The BioHub - by Avetix · Sep 3, 2026

Boost Pharma CEO Hans Schambye on pioneering an off-the-shelf cell therapy for brittle bone disease and lessons in biotech leadership.

Successful Cell Therapies Use Scalable 'Off-the-Shelf' Models, Not Bespoke Patient-Specific Ones

Many early cell therapies failed due to the impractical cost and complexity of individual manufacturing for each patient. Companies now succeeding are developing "off-the-shelf" treatments that don't require patient matching or immune suppression, creating a more scalable and commercially viable model similar to traditional drugs.

Episode 221 - Hans Schambye - CEO BOOST Pharma thumbnail

Episode 221 - Hans Schambye - CEO BOOST Pharma

The BioHub - by Avetix·3 months ago

Biotech Founders Fail When They Prioritize Scientific Perfection Over Developing a 'Good Enough' Product

A common pitfall for science-led companies is getting lost in the pursuit of academic perfection while forgetting the ultimate goal: developing a marketable product. Success requires shifting focus from perfect science to creating a product that is "good enough" to help patients, a mindset crucial for navigating the complexities of drug development.

Episode 221 - Hans Schambye - CEO BOOST Pharma thumbnail

Episode 221 - Hans Schambye - CEO BOOST Pharma

The BioHub - by Avetix·3 months ago

For First-Time CEOs, a 'Non-Destructive' Board Is the Minimum Requirement for Success

An experienced biotech CEO reveals a cynical but practical truth: the baseline for a good board is one that simply isn't destructive and doesn't make the CEO's job harder. New leaders should prioritize building a board with supportive, independent members who offer more than just investment capital, as investor-heavy boards can lack a company-first perspective.

Episode 221 - Hans Schambye - CEO BOOST Pharma thumbnail

Episode 221 - Hans Schambye - CEO BOOST Pharma

The BioHub - by Avetix·3 months ago

CEOs Need an External Mentor Because a Board Is Ultimately a Boss, Limiting True Honesty

While a board is crucial, it also determines a CEO's employment, creating a barrier to complete transparency about personal shortcomings or critical challenges. An external mentor provides a safe, confidential space for a CEO to be vulnerable, bounce ideas, and get candid advice on sensitive issues like team problems or hiring mistakes without fear of reprisal.

Episode 221 - Hans Schambye - CEO BOOST Pharma thumbnail

Episode 221 - Hans Schambye - CEO BOOST Pharma

The BioHub - by Avetix·3 months ago